Lanmer Group

About Lanmer Group

Lanmer Group is an EU-based life sciences company operating across the Europe at the intersection of laboratory infrastructure, clinical research, and deep-tech innovation. Founded in Estonia in 2014, Lanmer has evolved from a clinical research services company into a multi-entity group supporting research institutions, biotech companies, hospitals, and international sponsors across Europe. We operate through four specialized units: Lanmer Distro – Exclusive distribution and solution partner for leading global manufacturers, delivering complete laboratory workflows across molecular biology, cell culture, clinical diagnostics, and general lab infrastructure in the Baltic region. Lanmer CRO – A Europe-focused clinical research organization supporting US and EU biotecs with regulatory strategy, CTIS and RA/EC submissions, study start-up, monitoring, and quality oversight. We also support pharmaceutical and medical device companies in bringing medications and devices to the EU market through regulatory navigation, market entry strategy, and operational execution. Lanmer Hardware Venture Studio (HVS) – Supporting early-stage deep-tech, healthtech, cleantech, and foodtech hardware ventures from concept to commercialization. Langel Labs (coming soon) – A physical translational laboratory providing assay development, analytical testing, and central lab services. It supports HVS portfolio companies and external partners with scalable laboratory execution in research and clinical-grade environments. Lanmer integrates distribution, regulatory expertise, laboratory infrastructure, and commercialization strategy into one coordinated platform. We operate under strong quality and compliance standards across research and clinical settings. From laboratory bench to EU market access, Lanmer accelerates innovation into scalable, compliant, and market-ready solutions. EU-based. Execution-driven. Innovation-focused.